Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Viking Thera (VKTX)

Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,612,641
  • Shares Outstanding, K 110,268
  • Annual Sales, $ 0 K
  • Annual Income, $ -85,900 K
  • 60-Month Beta 1.03
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.92
Trade VKTX with:

Options Overview Details

View History
  • Implied Volatility 112.76% ( -9.47%)
  • Historical Volatility 71.01%
  • IV Percentile 59%
  • IV Rank 48.00%
  • IV High 234.70% on 02/16/24
  • IV Low 0.20% on 02/27/24
  • Put/Call Vol Ratio 0.15
  • Today's Volume 9,891
  • Volume Avg (30-Day) 15,768
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 147,496
  • Open Int (30-Day) 194,597

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.26
  • Number of Estimates 9
  • High Estimate -0.17
  • Low Estimate -0.33
  • Prior Year -0.19
  • Growth Rate Est. (year over year) -36.84%

Price Performance

See More
Period Period Low Period High Performance
1-Month
46.11 +12.14%
on 06/26/24
60.25 -14.17%
on 07/16/24
-1.03 (-1.95%)
since 06/21/24
3-Month
46.11 +12.14%
on 06/26/24
81.86 -36.83%
on 05/07/24
-12.14 (-19.01%)
since 04/22/24
52-Week
8.28 +524.52%
on 10/26/23
99.41 -47.98%
on 02/28/24
+36.35 (+236.65%)
since 07/21/23

Most Recent Stories

More News
Missed Out on Eli Lilly? These 2 Healthcare Stocks Have Big Catalysts on the Horizon.

Eli Lilly is still a smart pick, but these two stocks could grow more in the near term.

LLY : 865.97 (+0.99%)
VKTX : 51.71 (+1.59%)
GPCR : 36.59 (-2.27%)
3 Monster Stocks in the Making to Buy Right Now

They're small now, but these stocks could grow much larger.

VRTX : 495.91 (+0.88%)
NVO : 133.18 (+1.25%)
ZLDPF : 126.8900 (+0.71%)
CRSP : 56.24 (+3.08%)
VKTX : 51.71 (+1.59%)
Is Viking Therapeutics a Millionaire-Maker?

This biotech stock fits the profile of a potentially big winner to a T.

LLY : 865.97 (+0.99%)
NVO : 133.18 (+1.25%)
VKTX : 51.71 (+1.59%)
Is Viking Therapeutics the Best Biotech Stock for You?

Let's look beyond the hype the company is generating this year.

LLY : 865.97 (+0.99%)
VKTX : 51.71 (+1.59%)
NVO : 133.18 (+1.25%)
Not Sure Which Weight Loss Stock to Buy? Invest in This ETF

Many healthcare companies have been eagerly developing new weight loss drugs in an effort to cash in ...

LLY : 865.97 (+0.99%)
VKTX : 51.71 (+1.59%)
HRTS : 34.84 (+1.57%)
Is Viking Therapeutics Stock Running Out of Steam?

Viking's stock has tripled in less than a year, and its red-hot valuation could have investors thinking twice about buying it today.

VKTX : 51.71 (+1.59%)
Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics

Both competitors have promising lead programs, and enough cash, too.

LLY : 865.97 (+0.99%)
ALT : 6.37 (+1.43%)
VKTX : 51.71 (+1.59%)
Eli Lilly Rose More Than 50% So Far This Year. Can It Soar Past $1,000 in the 2nd Half?

This pharma company is posting double-digit revenue growth.

GS : 487.04 (+0.44%)
NVO : 133.18 (+1.25%)
AMGN : 335.97 (+1.41%)
VKTX : 51.71 (+1.59%)
LLY : 865.97 (+0.99%)
Forget Eli Lilly: 3 Biotech Stocks to Buy Instead

Eli Lilly is a good stock to buy, but these should be even better.

LLY : 865.97 (+0.99%)
AMGN : 335.97 (+1.41%)
VRTX : 495.91 (+0.88%)
VKTX : 51.71 (+1.59%)
Viking Therapeutics Stock Is Up by 154% Since January -- Can It Double Again in the Second Half of the Year?

It's a tough act to follow.

LLY : 865.97 (+0.99%)
VKTX : 51.71 (+1.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA...

See More

Key Turning Points

3rd Resistance Point 56.03
2nd Resistance Point 54.00
1st Resistance Point 52.85
Last Price 51.71
1st Support Level 49.67
2nd Support Level 47.64
3rd Support Level 46.49

See More

52-Week High 99.41
Fibonacci 61.8% 64.60
Fibonacci 50% 53.85
Last Price 51.71
Fibonacci 38.2% 43.09
52-Week Low 8.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar